Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART

Background: In South African antiretroviral guidelines, selected patients failing second-line protease inhibitor (PI)-based therapy qualify for genotypic resistance testing – those with PI resistance receive darunavir-based third-line regimens; those without PI resistance continue current regimen wi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ying Zhao, Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens, Graeme Meintjes
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	AOSIS 2024-04-01
Edice:	Southern African Journal of HIV Medicine
Témata:	antiretroviral therapy dolutegravir hiv virologic failure third-line.
On-line přístup:	https://sajhivmed.org.za/index.php/hivmed/article/view/1567
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!